Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Trial of Oral Digoxin In NASH (CODIN)

NCT06588699 is registered in ClinicalTrials.gov with Yale University as lead sponsor.

NCT NCT06588699
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06588699 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Trial of Oral Digoxin In NASH (CODIN)
Lead sponsor
Yale University
Phase
Phase 2
Overall status
Recruiting
Start date
June 5, 2025
Completion date
January 31, 2029
Enrollment
144 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

fatty liver disease, fatty liver disease, nonalcoholic, mash, mash - metabolic dysfunction-associated steatohepatitis, mash with fibrosis, masld, nafld, nash